United States · Venture startup

Who invested in e-Kare

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

Undisclosedraised across 1 round since 2015, from 1 source

Latest round
VentureMay 2015
Investors
1
See who backed them

The rounds

  1. May 2015
    VentureAmount undisclosed

    From a historical funding record

Founders and team

From e-Kare's own website: 14 on the team.

  • Kok van der MeijCEO Of Ekare Europe B.v.
  • Patrick ChengCEO
  • Dan YorkChief Commercial Officer
  • Kyle L. Wu MdChief Medical Officer
  • Özgür GülerCTO
  • Anthony PintoVP, Business Development
  • Brian McmanusVP, Clinical Operations
  • Necip GurlerVP of Research & Development
  • Raphael YaakovMs VP, Clinical Development
  • Stephen DoadesVP, Region Eu / Uk
  • Fiona AdamBoard Member
  • Lucy ChampBd Director, Region Eu / Uk
  • Rupa VassMarketing Director
  • Vincent de WaardDIRECTOR INTERNATIONAL BUSINESS DEVELOPMENT (eKare EUROPE)

Everyone who backed them

CIT GAP FundsVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about e-Kare

Who invested in e-Kare?

e-Kare's investors include CIT GAP Funds.

How much has e-Kare raised?

e-Kare has raised 1 round since 2015, none with a disclosed amount.

When did e-Kare last raise?

e-Kare's most recent round was a Venture in May 2015.

Who backed e-Kare first?

e-Kare's first round on record, in May 2015, was backed by CIT GAP Funds.

What stage is e-Kare at?

e-Kare's latest named round is a Venture, in May 2015.

Where is e-Kare based?

e-Kare is based in the United States.

Companies like e-Kare

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.